|
1
|
Hausen H: Papillomaviruses in the
causation of human cancers – a brief histological account.
Virology. 44:219–224. 2009.
|
|
2
|
Senba M, Mori N and Wada A: Oncogenesis of
human papilomavirus (HPV). DNA Tumor Virus. Tao HE: Nova Science
Publishers Inc.; New York: pp. 75–102. 2009
|
|
3
|
Senba M, Mori N and Wada A: Oncogenesis
and the link between inflammation and cancer due to human
papillomavirus (HPV) infection, and the development of vaccine
control strategies. Cancer Res J. 2:307–338. 2009.
|
|
4
|
Smith JS, Herrero R, Bosetti C, et al:
Herpes simplex virus-2 as a human papillomavirus cofactor in the
etiology of invasive cervical cancer. J Natl Cancer Inst.
94:1604–1613. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Smith JS, Munoz N, Herrero R, et al:
Evidence for Chlamydia trachomatis as a human papillomavirus
cofactor in the etiology of invasive cervical cancer in Brazil and
the Philippines. J Infect Dis. 185:324–331. 2002.
|
|
6
|
Karin M and Greten FR: NF-κB: linking
inflammation and immunity to cancer development and progression.
Nat Rev Immunol. 5:749–759. 2005.
|
|
7
|
Karin M: Nuclear factor-κB in cancer
development and progression. Nature. 441:749–759. 2006.
|
|
8
|
Kiriakidis S, Andreakos E, Monaco C, et
al: VEGF expression in human macrophages is NF-κB-dependent:
studies using adenoviruses expressing the endogenous NF-κB
inhibitor IκBα and kinase-defective form of the IκB kinase 2. J
Cell Sci. 116:665–674. 2003.
|
|
9
|
Senba M, Kumatori A, Fujita S, et al: The
prevalence of human papillomavirus genotypes in penile cancers from
northern Thailand. J Med Virol. 78:1341–1346. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fujita S, Senba M, Kumatori A, et al:
Human papillomavirus infection in oral verrucous carcinoma:
genotyping analysis and inverse correlation with p53 expression.
Pathobiology. 75:257–264. 2008. View Article : Google Scholar
|
|
11
|
Senba M, Mori N, Wada A, et al: Human
papillomavirus genotypes in penile cancers from Japanese patients
and NF-κB activation. Oncol Lett. 1:267–272. 2010.PubMed/NCBI
|
|
12
|
Senba M, Buziba N, Mori N, et al:
Detection of human papillomavirus and cellular regulators
p16INK4a, p53, and NF-κB in penile cancer cases in
Kenya. Acta Virol. 53:43–48. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Espey DK, Wu XC, Swan J, et al: Annual
report to the nation on the status of cancer, 1975–2004, featuring
cancer in American Indians and Alaska natives. Cancer.
110:2119–2152. 2007.
|
|
14
|
Parkin DM and Bray F: The burden of
HPV-related cancers. Vaccine. 24(Suppl 3): 11–25. 2006. View Article : Google Scholar
|
|
15
|
Bryan JT, Taddeo F, Skulsky D, et al:
Detection of specific human papillomavirus types in
paraffin-embedded sections of cervical carcinomas. J Med Virol.
78:117–124. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Louie KS, Sanjose S and Mayaud P:
Epidemiology and prevention of human papillomavirus and cervical
cancer in sub-Sahara Africa: a comprehensive review. Trop Med Int
Health. 14:1287–1302. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yamada R, Sasagawa T, Kirumbi LW, et al:
Human papillomavirus infection and cervical abnormalities in
Nairobi, Kenya, an area with a high prevalence of human
immunodeficiency virus infection. J Med Virol. 80:847–855. 2008.
View Article : Google Scholar
|
|
18
|
Nees M, Geoghegan JM, Hyman T, et al:
Papillomavirus type 16 oncogenes downregulate expression of
interferon-responsive genes and upregulate proliferation-associated
and NF-κB-responsive genes in cervical keratinocytes. J Virol.
75:4283–4296. 2001.PubMed/NCBI
|
|
19
|
Spitkovsky D, Hehner SP, Hofmann TG, et
al: The human papillomavirus oncoprotein E7 attenuates NF-κB
activation by targeting IκB kinase complex. J Biol Chem.
277:25576–25582. 2002.PubMed/NCBI
|
|
20
|
Havard L, Delvenne P, Frare P, et al:
Differential production of cytokines and activation of NF-κB in HPV
transformed keratinocytes. Virology. 298:271–285. 2002.
|
|
21
|
Havard L, Rahmouni S, Boniver J, et al:
High levels of p105 (NF-κB1) and p100 (NF-κB2) proteins in HPV
16-transformed keratinocytes. Virology. 331:357–366. 2005.
|
|
22
|
Mishra A, Bharti AC, Varghese P, et al:
Differential expression and activation of NF-κB family proteins
during oral carcinogenesis: role of high risk human papillomavirus
infection. Int J Cancer. 119:2840–2850. 2006.
|
|
23
|
James MA, Lee JH and Klingelhutz AJ: Human
papillomavirus type 16 E6 activates NF-κB, induces cIAP-2
expression, and protects against apoptosis in a PDZ binding
motif-dependent manner. J Virol. 80:5301–5307. 2006.
|
|
24
|
Senba M, Mori N, Fujita S, et al:
Relationship among human papillomavirus infection,
p16INK4a, p53 and NF-κB activation in penile cancer from
northern Thailand. Oncol Lett. 1:599–603. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Munger K, Baldwin A, Edwards KM, et al:
Mechanisms of human papillomavirus-induced oncogenesis. J Virol.
78:11451–11460. 2004. View Article : Google Scholar : PubMed/NCBI
|
